Amundi Asset Management US’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$15.9M Buy
650,671
+127,902
+24% +$2.89M 0.01% 730
2020
Q4
$10.2M Sell
522,769
-143,062
-21% -$2.63M 0.01% 800
2020
Q3
$11.6M Buy
665,831
+196,871
+42% +$4.2M 0.01% 701
2020
Q2
$12.3M Buy
+468,960
New +$11.6M 0.01% 639

Other funds holding PAHC

Amundi Asset Management US's PAHC Position: Q1 2021 in Review

Amundi Asset Management US increased its Phibro Animal Health (PAHC) stake by 24% in Q1 2021, buying an estimated $2.89M and bringing the position to 650,671 shares worth $15.9M. The position accounts for 0.01% of the portfolio, ranked #730.

Amundi Asset Management US first reported a position in PAHC in Q2 2020 and has held it in 4 quarters since. 141 funds tracked by Wall St. Rank hold PAHC as of Q1 2021.

  • Amundi Asset Management US held 650,671 shares of Phibro Animal Health worth $15.9M as of Q1 2021.
  • Amundi Asset Management US bought 127,902 Phibro Animal Health shares in Q1 2021, an estimated $2.89M.
  • Phibro Animal Health made up 0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #730 holding.
  • Amundi Asset Management US first reported a position in Phibro Animal Health in Q2 2020 and has held it in 4 quarters since.
  • 141 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.